SynthesisFrontiers in immunology2025

Long-term outcomes of PD-1 inhibitors plus chemotherapy as first-line treatment for advanced HER2-negative gastric cancer: an updated systematic review and meta-analysis.

Juping Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.